Article
The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide.
Pharmacogenomics - 1 Jan 2011
Dziedziejko Violetta, Kurzawski Mateusz, Safranow Krzysztof, Chlubek Dariusz, Pawlik Andrzej
Abstract excerpt
AIM: Leflunomide is the drug used in the therapy for rheumatoid arthritis (RA). Previous studies indicated that the efficacy of the therapy with antirheumatic drugs is more effective in men than in women. Moreover, estrogens can decrease the anti-inflammatory action of leflunomide. Estrogens act through the estrogen receptors ESR1 and ESR2. In ESR1 and ESR2 genes, several polymorphisms have been detected. The aim...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
